Pacira Pharmaceuticals, Inc. announced unaudited revenue results for the fourth quarter and full-year ended December 31, 2017. For the fourth quarter, the company reported total revenues of $79.1 million compared to $72.9 million for the prior year. Net EXPAREL sales were $78.7 million compared to $71.4 million for the prior year. For the year, the company reported total revenues of $286.6 million compared to $276.4 million for the prior year. Net EXPAREL sales were $282.9 million compared to $265.8 million for the prior year. Full year sales were impacted by two fewer selling days in 2017 compared to 2016.